Shares of medical equipment maker Mettler-Toledo International (MTD) surged 5.14% in the pre-market Friday, after the company provided an upbeat annual profit forecast for 2025.
Mettler-Toledo expects its adjusted profit per share for the full year 2025 to be between $42.35 and $43.00, exceeding analysts' average estimate of $42.13. The company cited strong demand for its laboratory instruments used in drug development as a key driver behind the bullish profit outlook.
The positive annual forecast comes on the heels of Mettler-Toledo's better-than-expected fourth quarter performance. For the period ended December 31st, the company reported an adjusted profit of $12.41 per share, beating Wall Street's consensus estimate of $11.71 per share. Quarterly sales also topped expectations, rising 12% year-over-year to $1.05 billion.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。